Physician profile
Xin Wei
NPI 1255783098
$6,681.71
in general payments reported to CMS, 2019-2025
14 companies · $1,208 in 2025
The $1,208 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $303 · 2023: $797 · 2024: $4,373 · 2025: $1,208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,587 · Travel and Lodging: $2,790 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,587.49 |
| Travel and Lodging | $2,790.03 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,875.40 | 2023-2025 | Corevalve Evolut R, Symplicity G3 |
| Edwards Lifesciences Corporation | $1,937.16 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Heartflow, INC. | $439.65 | 2024-2025 | |
| Abbott Laboratories | $354.34 | 2021-2023 | Optis, Diamondback Coronary |
| Abiomed | $172.34 | 2023-2024 | Impella |
| Amgen INC. | $162.14 | 2021-2023 | Repatha |
| Chiesi USA, INC. | $156.90 | 2023-2024 | Kengreal |
| Boston Scientific Corporation | $146.02 | 2023 | Watchman Access System |
| Novo Nordisk INC | $121.87 | 2024 | |
| Penumbra, INC. | $111.06 | 2023 | Indigo System |
| Cathworks, INC. | $84.12 | 2023 | Ffrangio |
| Philips North America LLC | $59.89 | 2021 | |
| Teleflex LLC | $40.59 | 2024 | Turnpike |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.23 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xin Wei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.